Exchange: NASDAQ·Updated 07:30 PM EDT
News
all
press releases
Omnicell President Sells 6,753 Shares
Key PointsThe disposal comprised 6,753 shares representing a total transaction value of ~$250,000...
Nasdaq News: Markets
More News
Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins
OMCL raised its 2026 EPS outlook after a strong second quarter, but rising memory-chip costs and delayed hospital purchases could test margins.
Zacks
OMCL Falls 20.1% in a Month as Booking and Margin Risks Build
Omnicell's 20.1% monthly slide reflects booking uncertainty, margin pressure and refresh-cycle risks despite a higher 2026 profit outlook.
Zacks
Here's Why Omnicell (OMCL) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
OMCL Q2 Earnings Call Highlights Titan XT Pipeline Growth
Omnicell highlights Titan XT and OmniSphere momentum, and raises profit outlook, while customer approval timing weighs on product bookings.
Zacks
Omnicell (OMCL) Q2 Earnings and Revenues Top Estimates
Omnicell (OMCL) delivered earnings and revenue surprises of +95.83% and +0.83%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Omnicell Announces Second Quarter 2026 Financial Results
Omnicell, Inc. (NASDAQ:OMCL) (Omnicell, we, our, or the Company), a leading healthcare technology provider focused on empowering autonomous medication management, today reported financial results for the second quarter ended June 30, 2026. Second quarter results reflected continued execution across...
Business Wire
Omnicell to Report Q2 Earnings: OmniSphere in Focus
OMCL heads into Q2 earnings with OmniSphere adoption, Connected Devices execution and recurring revenue growth ahead of July 30 results.
Zacks
Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026
Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, will release its financial results for the second quarter 2026, before market open on Thursday, July 30, 2026. The Company will host a conference call and webcast to...
Business Wire
Should You Continue to Hold OMCL Stock in Your Portfolio Now?
Omnicell is advancing its autonomous pharmacy vision and expanding SaaS offerings, but tariffs and fierce competition could test its growth path.
Zacks

Advertisement|Remove ads.